Opdivo (nivolumab)

pCPA File Number: 20879
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Melanoma
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CADTH Project Number:
pCODR 10063
pCPA Engagement Letter Issued:
Negotiation Process Concluded: